Towards Healthcare
Cell Therapy Manufacturing Market Leads 16% CAGR by 2034

Cell Therapy Manufacturing Market Revenue: $23.27 Bn by 2034

The cell therapy manufacturing market size is calculated at $6.12 bn in 2025 is to hit $23.27 bn by 2034. In 2024, key developments in cell therapy manufacturing include Sony's collaboration with Cellares to integrate advanced cell analysis, Quell Therapeutics' partnership with eXmoor Pharma for CAR-Treg trials, LumaCyte's predictive CAR T analytics, and FDA approval of lifileucel for melanoma treatment.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Cell Therapy Manufacturing Market Assessment

  • Overview
  • Global Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • HIV
    • Autoimmune Disorders
    • Immune Deficiencies
    • Cancer
    • Neurological Disorders
  • Global Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Injectable
    • Infusion
    • Implantable Bio-Scaffold
  • Global Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Cell Type (2021 – 2033)
    • Hematopoietic (Blood-Forming) Stem Cells (HSC)
    • Skeletal Muscle Stem Cells
    • Mesenchymal Stem Cells
    • Lymphocytes
    • Dendritic Cells
    • Pancreatic Islet Cells
    • CAR-T Cells
  • Global Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospital Settings
    • Intensive Outpatient Treatment Centers
    • Academic and Research Institutes
    • Specialty Clinics
  • Global Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Malaysia
      • Philippines
    • Latin America
      • Brazil
      • Rest of Latin America
    • Middle East & Africa (MEA)
      • GCC
      • North Africa
      • South Africa
      • Rest of the Middle East & Africa

North America Cell Therapy Manufacturing Market Assessment

  • Overview
  • North America Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • HIV
    • Autoimmune Disorders
    • Immune Deficiencies
    • Cancer
    • Neurological Disorders
  • North America Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Injectable
    • Infusion
    • Implantable Bio-Scaffold
  • North America Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Cell Type (2021 – 2033)
    • Hematopoietic (Blood-Forming) Stem Cells (HSC)
    • Skeletal Muscle Stem Cells
    • Mesenchymal Stem Cells
    • Lymphocytes
    • Dendritic Cells
    • Pancreatic Islet Cells
    • CAR-T Cells
  • North America Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospital Settings
    • Intensive Outpatient Treatment Centers
    • Academic and Research Institutes
    • Specialty Clinics
  • North America Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • U.S.
    • Canada

Europe Cell Therapy Manufacturing Market Assessment

  • Overview
  • Europe Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • HIV
    • Autoimmune Disorders
    • Immune Deficiencies
    • Cancer
    • Neurological Disorders
  • Europe Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Injectable
    • Infusion
    • Implantable Bio-Scaffold
  • Europe Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Cell Type (2021 – 2033)
    • Hematopoietic (Blood-Forming) Stem Cells (HSC)
    • Skeletal Muscle Stem Cells
    • Mesenchymal Stem Cells
    • Lymphocytes
    • Dendritic Cells
    • Pancreatic Islet Cells
    • CAR-T Cells
  • Europe Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospital Settings
    • Intensive Outpatient Treatment Centers
    • Academic and Research Institutes
    • Specialty Clinics
  • Europe Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • U.K.
    • Germany
    • France

Asia-Pacific Cell Therapy Manufacturing Market Assessment

  • Overview
  • Asia-Pacific Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • HIV
    • Autoimmune Disorders
    • Immune Deficiencies
    • Cancer
    • Neurological Disorders
  • Asia-Pacific Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Injectable
    • Infusion
    • Implantable Bio-Scaffold
  • Asia-Pacific Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Cell Type (2021 – 2033)
    • Hematopoietic (Blood-Forming) Stem Cells (HSC)
    • Skeletal Muscle Stem Cells
    • Mesenchymal Stem Cells
    • Lymphocytes
    • Dendritic Cells
    • Pancreatic Islet Cells
    • CAR-T Cells
  • Asia-Pacific Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospital Settings
    • Intensive Outpatient Treatment Centers
    • Academic and Research Institutes
    • Specialty Clinics
  • Asia-Pacific Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines

Latin America Cell Therapy Manufacturing Market Assessment

  • Overview
  • Latin America Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • HIV
    • Autoimmune Disorders
    • Immune Deficiencies
    • Cancer
    • Neurological Disorders
  • Latin America Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Injectable
    • Infusion
    • Implantable Bio-Scaffold
  • Latin America Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Cell Type (2021 – 2033)
    • Hematopoietic (Blood-Forming) Stem Cells (HSC)
    • Skeletal Muscle Stem Cells
    • Mesenchymal Stem Cells
    • Lymphocytes
    • Dendritic Cells
    • Pancreatic Islet Cells
    • CAR-T Cells
  • Latin America Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospital Settings
    • Intensive Outpatient Treatment Centers
    • Academic and Research Institutes
    • Specialty Clinics
  • Latin America Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • Brazil
    • Rest of Latin America

Middle East & Africa (MEA) Cell Therapy Manufacturing Market Assessment

  • Overview
  • Middle East & Africa (MEA) Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • HIV
    • Autoimmune Disorders
    • Immune Deficiencies
    • Cancer
    • Neurological Disorders
  • Middle East & Africa (MEA) Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Injectable
    • Infusion
    • Implantable Bio-Scaffold
  • Middle East & Africa (MEA) Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Cell Type (2021 – 2033)
    • Hematopoietic (Blood-Forming) Stem Cells (HSC)
    • Skeletal Muscle Stem Cells
    • Mesenchymal Stem Cells
    • Lymphocytes
    • Dendritic Cells
    • Pancreatic Islet Cells
    • CAR-T Cells
  • Middle East & Africa (MEA) Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospital Settings
    • Intensive Outpatient Treatment Centers
    • Academic and Research Institutes
    • Specialty Clinics
  • Middle East & Africa (MEA) Cell Therapy Manufacturing Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Company Profiles

  • Merck KGaA
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Thermo Fisher Scientific
  • Catalent, Inc
  • Bio-Techne
  • Cytiva
  • Lonza
  • The Discovery Labs
  • Novartis AG
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.

Conclusion & Recommendations

  • Insight Code: 5050
  • No. of Pages: 150
  • Format: PDF/PPT/Excel
  • Published: January 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of experience specializing in the healthcare sector. His expertise spans various facets of healthcare, including market dynamics, emerging trends, regulatory changes, and technology-driven innovations. With a keen eye for detail and a deep understanding of the global healthcare landscape, Rohan has been instrumental in shaping actionable insights that guide healthcare organizations in making informed, data-driven decisions.

Rohan's extensive experience covers a wide range of healthcare segments, from pharmaceuticals and biotechnology to medical devices and digital health. He has worked on numerous projects that evaluate market potential, assess competitive landscapes, and identify growth opportunities in rapidly evolving sectors in the healthcare industry.

His analytical acumen and ability to synthesize complex data have made him a trusted advisor to healthcare companies, helping them navigate the challenges and opportunities within the healthcare ecosystem. Rohan is particularly passionate about how technology and innovation are reshaping healthcare delivery, and his reports provide valuable insights into the impact of digital transformation on patient care, outcomes, and cost-efficiency.

With a strong track record in healthcare market research, Rohan continues to contribute significantly to the advancement of the industry by delivering data-backed strategies and comprehensive market analysis.

FAQ's

Technology plays a crucial role in the cell therapy market by enabling advancements in manufacturing processes, process optimization, gene editing and engineering, cell preservation and cryopreservation, analytics and quality control, and personalized medicine approaches. These technological advancements are driving the growth and innovation in the field.

Cell therapies are subject to rigorous regulatory scrutiny to ensure safety, efficacy, and quality. Regulatory considerations include compliance with good manufacturing practices, demonstration of product consistency and reproducibility, evaluation of long-term safety and efficacy data, and adherence to regulatory guidelines specific to cell therapies.

The cell therapy market holds immense potential for growth and innovation. With ongoing advancements in technology, manufacturing processes, and regulatory frameworks, as well as increasing investments in research and development, the future prospects for the cell therapy market are promising. The market is expected to expand into new disease areas, witness the development of more advanced therapies, and improve patient outcomes.

U.S. National Library of Medicine, National Cancer Institute; and International Society for Cell and Gene Therapy

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 515

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 515